The basic principles of managing the patients with impaired tone after focal brain damage
- Authors: Khatkova S.E1,2, Orlova O.R3, Botsina A.Y.4, Shikhkerimov R.K5, Kovalenko A.P6
-
Affiliations:
- Treatment and Rehabilitation Center of the Ministry of Health of the Russian Federation
- A.I.Burnazyan Federal Medical Biophysical Center FMBA of Russia
- I.M.Sechenov First Moscow Medical University of the Ministry of Health of the Russian Federation
- I.V.Davydovskiy City Clinical Hospital of the Department of Health of Moscow
- Ambulance unit of Polyclinic №166 of the Department of Health of Moscow
- S.M.Kirov Military Medical Academy
- Issue: Vol 18, No 2.1 (2016)
- Pages: 25-33
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/95157
- ID: 95157
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
S. E Khatkova
Treatment and Rehabilitation Center of the Ministry of Health of the Russian Federation; A.I.Burnazyan Federal Medical Biophysical Center FMBA of Russia
Email: hse15@mail.ru
д-р мед. наук, проф. каф. восстановительной медицины, спортивной медицины, курортологии и физиотерапии с курсом сестринского дела ФГБУ ГНЦ ФМБЦ им. А.И.Бурназяна, зав. отд. неврологии для БНМК; ФГАУ ЛРЦ 125367, Russian Federation, Moscow, Ivan'kovskoe shosse, d. 3
O. R Orlova
I.M.Sechenov First Moscow Medical University of the Ministry of Health of the Russian Federation
Email: ororlova@yandex.ru
д-р мед. наук, проф. каф. нервных болезней ИПО ГБОУ ВПО Первый МГМУ им. И.М.Сеченова; президент Межрегиональной общественной организации специалистов ботулинотерапии (МООСБТ); рук. неврологического отд-ния ЦМСиН 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
A. Yu Botsina
I.V.Davydovskiy City Clinical Hospital of the Department of Health of Moscow
Email: abotsina@gmail.com
канд. мед. наук, зав. отд-нием для больных с ОНМК ГБУЗ ГКБ им. И.В.Давыдовского 109240, Russian Federation, Moscow, ul. Yauzskaya, d. 11
R. K Shikhkerimov
Ambulance unit of Polyclinic №166 of the Department of Health of Moscow
Email: rodoss72@gmail.com
д-р мед. наук, зав. неврологическим отд-нием ГБУЗ ГП №166, гл. невролог ЮАО г. Москвы 115551, Russian Federation, Moscow, Domodedovskaya ul., d. 9
A. P Kovalenko
S.M.Kirov Military Medical Academy
Email: kvlnko73@gmail.com
канд. мед. наук, доц. каф. нервных болезней, гл. реабилитолог ФГБВОУ ВПО ВМА им. С.М.Кирова 194044, Russian Federation, Saint Petersburg, ul. Akademika Lebedeva, d. 6
References
- Куликов А.Ю., Угрехелидзе Д.Т. Фармакоэкономическое исследование применения препаратов ботулинического токсина при терапии постинсультной спастичности верхней конечности. Фармакоэкономика. Теория и практика. 2014; 2 (3): 28-37.
- Орлова О.Р., Тимербаева С.Л., Хатькова С.Е. и др. Ботулинотерапия в клинической практике. В кн.: Голубев В.Л. Избранные лекции по неврологии. II. М.: МЕДпресс - информ, 2012; с. 81-103.
- Триумфов А.В. Топическая диагностика заболеваний нервной системы. Л.: МЕДГИЗ, 1959.
- Хатькова С.Е., Конева Е.С., Сидякина И.В. Комплексная реабилитация больных с постинсультной спастичностью руки. Практическое руководство для врачей. М.: ФГБУ «Лечебно - реабилитационный центр», 2011.
- Хатькова С.Е., Орлова О.Р., Тимербаева С.Л., Познякова Е.В. Оценка клинического профиля пациентов со спастичностью верхней конечности, которым показаны инъекции ботулинического токсина типа А (по данным международного исследования). Журн. неврологии и психиатрии им. С.С.Корсакова, 2011; 111 (8): 23-6.
- Шабалов В.А., Декопов А.В., Томский А.А., Салова Е.М. Задняя селективная ризотомия в лечении тяжелого спастического синдрома при ДЦП. Вопр. нейрохирургии им. Н.Н.Бурденко. 2010; 74 (2): 14-8.
- Шихкеримов Р.К. Актуальность пациент - ориентированного подхода в реабилитации больных с постинсультной спастичностью. В кн.: Болезни мозга - медицинские и социальные аспекты. 2016; с. 147-64.
- Anakwenze O.A, Namdari S, Hsu J.E et al. Myotendinous lengthening of the elbow flexor muscles to improve active motion in patients with elbow spasticity following brain injury. J Shoulder Elbow Surg 2013; 22 (3): 318-22.
- Bakheit A.M, Fedorova N.V, Skoromets A.A et al. The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles. J Neurol Neurosurg Psychiatry 2004; 75 (11): 1558-61.
- Barnes M.P, Johnson G.R. UMN syndrome and spasticity. Cambridge University Press 2008.
- Brown M, Levack W, Mc Pherson K.M et al. Survival, momentum, and things that make me "me": patients' perceptions of goal setting after stroke. Disabil Rehabil 2014; 36 (12): 1020-6.
- Chen J.C, Shaw F.Z. Progress in sensorimotor rehabilitative physical therapy programs for stroke patients. World J Clin Cases 2014; 2 (8): 316-26.
- Dimitrijevic M.M, Dimitrijevic M.R, Illis L.S et al. Spinal cord stimulation for the control of spasticity in patients with chronic spinal cord injury: I. Clinical observations. Cent Nerv Syst Trauma 1986; 3 (2): 129-44.
- Doan Q.V, Gillard P, Brashear A et al. Cost - effectiveness of on a botulinumtoxin A for the treatment of wrist and hand disability due to upper - limb post - stroke spasticity in Scotland. Eur J Neurol 2013; 20 (5): 773-80.
- Etoom M, Hawamdeh M, Hawamdeh Z et al. Constraint - induced movement therapy as a rehabilitation intervention for upper extremity in stroke patients: systematic review and meta - analysis. Int J Rehabil Res 2016.
- Foley N, Murie-Fernandez M, Speechley M et al. Does the treatment of spastic equinovarus deformity following stroke with botulinum toxin increase gait velocity? A systematic review and meta - analysis. Eur J Neurol 2010; 17 (12): 1419-27.
- Francisco G.E, Boake C. Improvement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: a preliminary study. Arch Phys Med Rehabil 2003; 84 (8): 1194-9.
- Francisco G.E, Yablon S.A, Schiess M.C et al. Consensus panel guidelines for the use of intrathecal baclofen therapy in poststroke spastic hypertonia. Top Stroke Rehabil 2006; 13 (4): 74-85.
- Gracies J.M. Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle Nerve 2005; 31 (5): 535-51.
- Gracies J.M. Pathophysiology of spastic paresis. II: Emergence of muscle overactivity. Muscle Nerve 2005; 31 (5): 552-71.
- Gracies J.M. Coefficients of impairment in deforming spastic paresis. Ann Phys Rehabil Med 2015; 58 (3): 173-8.
- Gracies J.M, Bayle N, Vinti M et al. Five - step clinical assessment in spastic paresis. Eur J Phys Rehabil Med 2010; 46 (3): 411-21.
- Gracies J.M, Brashear A, Jech R et al. Safety and efficacy of abobotulinumtoxin A for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double - blind randomised controlled trial. Lancet Neurol 2015; 14 (10): 992-1001.
- Graham L.A. Management of spasticity revisited. Age Ageing 2013; 42 (4): 435-41.
- Hesse S, Mach H, Frohlich S et al. An early botulinum toxin A treatment in subacute stroke patients may prevent a disabling finger flexor stiffness six months later: a randomized controlled trial. Clin Rehabil 2012; 26 (3): 237-45.
- Hesse S, Reiter F, Konrad M, Jahnke M.T. Botulinum toxin type A and short - term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double - blind, placebo - controlled trial. Clin Rehabil 1998; 12 (5): 381-8.
- Horn T.S, Yablon S.A, Stokic D.S. Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury. Arch Phys Med Rehabil 2005; 86 (6): 1127-33.
- Ivanhoe C.B, Francisco G.E, Mc Guire J.R et al. Intrathecal baclofen management of poststroke spastic hypertonia: implications for function and quality of life. Arch Phys Med Rehabil 2006; 87 (11): 1509-15.
- Kaji R, Osako Y, Suyama K et al. Botulinum toxin type A in post - stroke lower limb spasticity: a multicenter, double - blind, placebo - controlled trial. J Neurol 2010; 257 (8): 1330-7.
- Kakuda W, Abo M, Momosaki R et al. Combined therapeutic application of botulinum toxin type A, low - frequency rTMS, and intensive occupational therapy for post - stroke spastic upper limb hemiparesis. Eur J Phys Rehabil Med 2012; 48 (1): 47-55.
- Kakuda W, Abo M, Shimizu M et al. A multi - center study on low - frequency rTMS combined with intensive occupational therapy for upper limb hemiparesis in post - stroke patients. J Neuroeng Rehabil 2012; 9 (1): 4.
- Katrak P.H, Cole A.M, Poulos C.J, Mc Cauley J.C. Objective assessment of spasticity, strength, and function with early exhibition of dantrolene sodium after cerebrovascular accident: a randomized double - blind study. Arch Phys Med Rehabil 1992; 73 (1): 4-9.
- Khalil N, Hutin E, Santiago T et al. Guided self - rehabilitation contracts and gait speed in chronic hemiparesis. A prospective study. Ann Phys Rehabil Med 2013; 56 (Suppl. 1): e45-e46.
- Lam K, Lau K.K, So K.K et al. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study. J Am Med Dir Assoc 2012; 13 (5): 477-84.
- Lance J. Symposium synopsis in spasticity; in Disordered motor control., Feldman R, Young R, Koella W, Editors. 1980, IL: Year Book Medical Publishers: Chicago; p. 487-9.
- Lance J.W. Symposium synopsis, in Spasticity: Disordered Motor Control., Feldman R.G, Young R.R, Koella W.P, Editors. 1980, IL: Yearbook Medical: Chicago; p. 485-94.
- Leathley M.J, Gregson J.M, Moore A.P et al. Predicting spasticity after stroke in those surviving to 12 months. Clin Rehabil 2004; 18 (4): 438-43.
- Lundstrom E, Smits A, Borg J, Terent A. Four - fold increase in direct costs of stroke survivors with spasticity compared with stroke survivors without spasticity: the first year after the event. Stroke 2010; 41 (2): 319-24.
- Lundstrom E, Smits A, Terent A, Borg J. Time - course and determinants of spasticity during the first six months following first - ever stroke. J Rehabil Med 2010; 42 (4): 296-301.
- Lundstrom E, Terent A, Borg J. Prevalence of disabling spasticity 1 year after first - ever stroke. Eur J Neurol 2008; 15 (6): 533-9.
- Mayer N.H. Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motoneuron lesion. Muscle Nerve Suppl 1997; 6: S1-13.
- Meythaler J.M, De Vivo M.J, Hadley M. Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury. Arch Phys Med Rehabil 1996; 77 (5): 461-6.
- Namdari S, Alosh H, Baldwin K et al. Outcomes of tendon fractional lengthenings to improve shoulder function in patients with spastic hemiparesis. J Shoulder Elbow Surg 2012; 21 (5): 691-8.
- Olvey E.L, Armstrong E.P, Grizzle A.J. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review. Clin Ther 2010; 32 (14): 2282-303.
- Peacock W.J, Staudt L.A. Functional outcomes following selective posterior rhizotomy in children with cerebral palsy. J Neurosurg 1991; 74 (3): 380-5.
- Pittock S.J, Moore A.P, Hardiman O et al. A double - blind randomised placebo - controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis 2003; 15 (4): 289-300.
- Price C.I, Pandyan A.D. Electrical stimulation for preventing and treating post - stroke shoulder pain: a systematic Cochrane review. Clin Rehabil 2001; 15 (1): 5-19.
- Remy-Neris O, Tiffreau V, Bouilland S, Bussel B. Intrathecal baclofen in subjects with spastic hemiplegia: assessment of the antispastic effect during gait. Arch Phys Med Rehabil 2003; 84 (5): 643-50.
- Rosales R.L, Kong K.H, Goh K.J et al. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial. Neurorehabil Neural Repair 2012; 26 (7): 812-21.
- Rousseaux M, Buisset N, Daveluy W et al. Long - term effect of tibial nerve neurotomy in stroke patients with lower limb spasticity. J Neurol Sci 2009; 278 (1-2): 71-6.
- Royal College of Physicians, British Society of Rehabilitation Medicine, Chartered Society of Physiotherapy, Neurology A.o.C.P.I.i., Spasticity in adults: management using botulinum toxin. National Guidelines 2009, London: RCP.
- Santamato A, Micello M.F, Panza F et al. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of pos t -stroke lower limb spasticity: a prospective open - label study. Eur J Phys Rehabil Med 2013; 49 (4): 483-9.
- Sheean G. The pathophysiology of spasticity. Eur J Neurol 2002 (9 Suppl. 1): 3-9; discussion 53-61.
- Sheean G. The neurophysiology of spasticity., in Upper Motor Neurone Syndrome and Spasticity., Barnes M.P, Johnson G.R, Editors. 2008, NY: Cambridge University Press: New York; p. 9-63.
- Sherrington C.S. The Integrative Action of the Nervous System. 1947, New Haven: CT: Yale University Press.
- Simpson D.M, Gracies J.M, Yablon S.A et al. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo - controlled study. J Neurol Neurosurg Psychiatry 2009; 80 (4): 380-5.
- Simpson D.M, Hallett M, Ashman E.J et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2016; 86 (19): 1818-26.
- Sommerfeld D.K, Eek E.U, Svensson A.K et al. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke 2004; 35 (1): 134-9.
- Tardieu C, Huet de la Tour E, Bret M.D, Tardieu G. Muscle hypoextensibility in children with cerebral palsy: I. Clinical and experimental observations. Arch Phys Med Rehabil 1982; 63 (3): 97-102.
- Tardieu G. Les feuillets de l’infirmité motrice cérébrale; in Evaluation et caractères distinctifs des diverses raideurs d’origine cérébrale. Association Nationale des IMC Ed.: Paris 1966; p. 1-28.
- Tardieu G, Lacert P. Le tonus et ses troubles en clinique. Encyclopédie medico - chirurgicale. Paris: Neurologie, 1977.
- Tardieu G, Shentoub S, Delarue R. A la recherche d'une technique de mesure de la spasticite. Rev Neurol (Paris) 1954; 91 (2): 143-4.
- Teasell R, Foley N, Salter K et al. Evidence-Based Review of Stroke Rehabilitation: executive summary, 16th edition. 2013; Available from: http://www.ebrsr.com/ [Accessed 17.03.2014 2014].
- Thieme H, Mehrholz J, Pohl M et al. Mirror therapy for improving motor function after stroke. Stroke 2013; 44 (1): e1-2.
- Tok F, Balaban B, Yasar E et al. The effects of onabotulinum toxin A injection into rectus femoris muscle in hemiplegic stroke patients with stiff - knee gait: a placebo - controlled, nonrandomized trial. Am J Phys Med Rehabil 2012; 91 (4): 321-6.
- Turner-Stokes L, Fheodoroff K, Jacinto J, Maisonobe P. Results from the Upper Limb International Spasticity Study-II (ULISII):a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real - life clinical management. BMJ Open 2013; 3 (6).
- Urban P.P., Wolf T, Uebele et al. Occurence and clinical predictors of spasticity after ischemic stroke. Stroke 2010; 41 (9): 2016-20.
- Welmer A.K, Widen Holmqvist L, Sommerfeld D.K. Location and severity of spasticity in the first 1-2 weeks and at 3 and 18 months after stroke. Eur J Neurol 2010; 17 (5): 720-5.
- Whitlock J.A. Neurophysiology of spasticity; in The Practical Management of Spasticity in Children and Adults, Glen M.B, Whyte J, Editors. 1990, PA: Lea & Febiger: Philadelphia; p. 8-33.
- Winstein C.J, Stein J, Arena R et al. Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2016.
- Wissel J, Schelosky L.D, Scott J et al. Early development of spasticity following stroke: a prospective, observational trial. J Neurol 2010; 257 (7): 1067-72.
- Wissel J, Verrier M, Simpson D.M et al. Post - stroke spasticity: predictors of early development and considerations for therapeutic intervention. PM R 2015; 7 (1): 60-7.
- Wissel J, Ward A.B, Erztgaard P et al. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med 2009; 41 (1): 13-25.